Distinctive actions of interleukin-13 and interleukin-4 on growth of hematopoietic progenitors

International Journal of Oncology

Volumn 14, Issue 3, 1999, Pages 471-477

  Sugawara, Takayuki ^a   Katayama, Naoyuki ^a   Nishii, Kazuhiro ^a   Mahmud, Nadim ^a   Mitani, Hidetsugu ^a   Ohishi, Kohshi ^a   Masuya, Masahiro ^a   Minami, Nobuyuki ^b   Shiku, Hiroshi ^a  

^a MIE UNIVERSITY   (Japan)

^b MIE UNIVERSITY HOSPITAL   (Japan)

Author keywords

Hematopoietic progenitors; IL 13; IL 4

Indexed keywords

FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 13; INTERLEUKIN 4; STEM CELL FACTOR;

ANIMAL; ARTICLE; CLONOGENIC ASSAY; DRUG EFFECT; DRUG INTERACTION; HEMATOPOIETIC STEM CELL; HUMAN; MOUSE; PHYSIOLOGY;

ANIMALS; COLONY-FORMING UNITS ASSAY; DRUG INTERACTIONS; FLUOROURACIL; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-13; INTERLEUKIN-4; MICE; STEM CELL FACTOR;

EID: 0033090697     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.14.3.471     Document Type: Article

References (42)

1. Metcalf D: Hematopoietic regulators: redundancy or subtlety? Blood 82: 3515-3523, 1993.
2. Ogawa M: Differentiation and proliferation of hematopoietic stem cells. Blood 81: 2844-2853, 1993.
3. Williams ME and Quesenberry PJ: Hematopoietic growth factors. Hematol Pathol 6: 105-124, 1992.
4. Moore MAS: Clinical implication of positive and negative hematopoietic stem cell regulators. Blood 78: 1-19, 1991.
5. Rennick D, Jackson J, Yang G, Wideman J, Lee F and Hudak S: Interleukin-6 interacts with interleukin-4 and other hematopoietic growth factors to selectively enhance the growth of megakaryocytic, erythroid, myeloid, and multipotential progenitor cells. Blood 73: 1828-1835, 1989.
6. Kishi K, Ihle JN, Urdal DL and Ogawa M: Murine B-cell stimulatory factor-1 (BSF-1)/interleukin-4 (IL-4) is a multilineage colony-stimulating factor that acts directly on primitive hemopoietic progenitors. J Cell Physiol 139: 463-468, 1989.
7. Ema H, Suda T, Nagayoshi K, Miura Y, Civin CI and Nakauchi H: Target cells for granulocyte colony-stimulating factor, interleukin-3, and interleukin-5 in differentiation pathways of neutrophils and eosinophils. Blood 76: 1956-1961, 1990.
8. Yamaguchi Y, Suda T, Suda J, Eguchi M, Miura Y, Harada N, Tominaga A and Takatsu K: Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J Exp Med 167: 43-56, 1988.
9. Kishimoto T: The biology of interleukin-6. Blood 74: 1-10, 1989.
10. Ikebuchi K, Wong GG, Clark SC, Ihle JN, Hirai Y and Ogawa M: Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. Proc Natl Acad Sci USA 84: 9035-9039, 1987.
11. Ishibashi T, Kimura H, Uchida T, Kariyone S, Friese P and Burstein SA: Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro. Proc Natl Acad Sci USA 86: 5953-5957, 1989.
12. Jansen JH, Kluin-Nelemans JC, van Damme J, Wientjens GJHM, Willemze R and Fibbe WE: Interleukin 6 is a permissive factor for monocytic colony formation by human hematopoietic progenitor cells. J Exp Med 175: 1151-1154, 1992.
13. Jacobsen SEW, Veiby OP and Smeland EB: Cytotoxic lymphocyte maturation factor (interleukin 12) is a synergistic growth factor for hematopoietic stem cells. J Exp Med 178: 413-418, 1993.
14. Ploemacher RE, van Soest PL, Voorwinden H and Boudewijn A: Interleukin-12 synergizes with interleukin-3 and steel factor to enhance recovery of murine hemopoietic stem cells in liquid culture. Leukemia 7: 1381-1388, 1993.
15. Hirayama F, Katayama N, Neben S, Donaldson D, Nickbarg EB, Clark SC and Ogawa M: Synergistic interaction between interleukin-12 and steel factor in support of proliferation of murine lymphohematopoietic progenitors in culture. Blood 83: 92-98, 1994.
16. Ikebuchi K, Clark SC, Ihle JN, Souza LM and Ogawa M: Granulocyte colony-stimulating factor enhances interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. Proc Natl Acad Sci USA 85: 3445-3449, 1988.
17. Ku H, Yonemura Y, Kaushansky K and Ogawa M: Thrombopoietin, the ligand for the Mp1 receptor, synergizes with steel factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice. Blood 87: 4544-4551, 1996.
18. Sitnicka E, Lin N, Priestley GV, Fox N, Broudy VC, Wolf NS and Kaushansky K: The effect of thrombopoietin on the proliferation and differentiation of murine hematopoietic stem cells. Blood 87: 4998-5005, 1996.
19. -) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin. J Exp Med 183: 2551-2558, 1996.
20. Itoh R, Katayama N, Kato T, Mahmud N, Masuya M, Ohishi K, Minami N, Miyazaki H and Shiku H: Activity of the ligand for c-mpl, thrombopoietin, in early haemopoiesis. Br J Haematol 94: 228-235, 1996.
21. Borge OJ, Ramsfjell V, Veiby OP, Murphy Jr MJ, Lok S and Jacobsen SEW: Thrombopoietin, but not erythropoietin promotes viability and inhibits apoptosis of multipotent murine hematopoietic progenitor cells in vitro. Blood 88: 2859-2870, 1996.
22. Minty A, Chalon P, Derocq J-M, Dumont X, Guillemot J-C, Kaghad M, Labit C, Leplatois P, Liauzum P, Miloux B, Minty C, Casellas P, Loison G, Lupker J, Shire D, Ferrara P and Caput D: Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 362: 248-250, 1993.
23. McKenzie ANJ, Culpepper JA, de Waal Malefyt R, Brière F, Punnonen J, Aversa G, Sato A, Dang W, Cocks BG, Menon S, de Vries JE, Banchereau J and Zurawski G: Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc Natl Acad Sci USA 90: 3735-3739, 1993.
24. Punnonen J, Aversa G, Cocks BG, McKenzie ANJ, Menon S, Zurawski G, de Waal Malefyt R and de Vries JE: Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci USA 90: 3730-3734, 1993.
25. Defrance T, Carayon P, Billian G, Guillemot J-C, Minty A, Caput D and Ferrara P: Interleukin 13 is a B cell stimulating factor. J Exp Med 179: 135-143, 1994.
26. Zurawski G and de Varies JE: Interleukin-13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 15: 19-26, 1994.
27. Nilsson G and Nilsson K: Effects of interleukin (IL)-13 on immediate-early response gene expression, phenotype and differentiation of human mast cells: comparison with IL-4. Eur J Immunol 25: 870-873, 1995.
28. Zurawski SM, Vega Jr F, Huyghe B and Zurawski G: Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J 12: 2663-2670, 1993.
29. Vita N, Lefort S, Laurent P, Caput D and Ferrara P: Characterization and comparison of the interleukin 13 receptor with the interleukin 4 receptor on several cell types. J Biol Chem 270: 3512-3517, 1995.
30. Jacobsen SEW, Okkenhaug C, Veiby OP, Caput D, Ferrara P and Minty A: Interleukin 13: novel role in direct regulation of proliferation and differentiation of primitive hematopoietic progenitor cells. J Exp Med 180: 75-82, 1994.
31. Sakamoto O, Hashiyama M, Minty A, Ando M and Suda T: Interleukin-13 selectively suppresses the growth of human macrophage progenitors at the late stage. Blood 85: 3487-3493, 1995.
32. Hodgson GS and Bradley TR: Properties of haematopoietic stem cells surviving 5-fluorouracil treatment: evidence for a pre-CFU-S cell? Nature 281: 381-382, 1979.
33. Lerner C and Harrison DE: 5-fluorouracil spares hemopoietic stem cells responsible for long-term repopulation. Exp Hematol 18: 114-118, 1990.
34. Katayama N, Clark SC and Ogawa M: Growth factor requirement for survival in cell-cycle dormancy of primitive murine lymphohematopoietic progenitors. Blood 81: 610-616, 1993.
35. Katayama N, Shin J-P, Nishikawa S-i, Kina T, Clark SC and Ogawa M: Stage-specific expression of c-kit protein by murine hematopoietic progenitors. Blood 82: 2353-2360, 1993.
36. Tanaka R, Katayama N, Ohishi K, Mahmud N, Itoh R, Tanaka Y, Komada Y, Minami N, Sakurai M, Shirakawa S and Shiku H: Accelerated cell-cycling of hematopoietic progenitor cells by growth factors. Blood 86: 73-79, 1995.
37. Ohishi K, Katayama N, Itoh R, Mahmud N, Miwa H, Kita K, Minami N, Shirakawa S, Lyman SD and Shiku H: Accelerated cell-cycling of hematopoietic progenitors by the flt3 ligand that is modulated by transforming growth factor-ß. Blood 87: 1718-1727, 1996.
38. Musashi M, Clark SC, Sudo T, Urdal DL and Ogawa M: Synergistic interactions between interleukin-11 and interleukin-4 in support of proliferation of primitive hematopoietic progenitors of mice. Blood 78: 1448-1451, 1991.
39. Mosley B, Beckmann MP, March CJ, Idzerda RL, Gimpel SD, VandenBos T, Friend D, Alpert A, Anderson D, Jackson J, Wignall JM, Smith C, Gallis B, Sims JE, Urdal D, Widmer MB, Cosman D and Park LS: The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms. Cell 59: 335-348, 1989.
40. Hilton DJ, Zhang J-G, Metcalf D, Alexander WS, Nicola NA and Willson TA: Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc Natl Acad Sci USA 93: 497-501, 1996.
41. Xi X, Schlegel N, Caen JP, Minty A, Fournier S, Caput D, Ferrara P and Han ZC: Differential effects of recombinant human interleukin-13 on the in vitro growth of human haemopoietic progenitor cells. Br J Haematol 90: 921-927, 1995.
42. Reddy GPV, Tiarks CY, Pang L, Wuu J, Hsieh C-C and Quesenberry PJ: Cell cycle analysis and synchronization of pluripotent hematopoietic progenitor stem cells. Blood 90: 2293-2299, 1997.